Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD Trial.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD Trial.
Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD Trial. J Am Soc Nephrol. 2022 01; 33(1):225-237.
View in:
PubMed
subject areas
Aged
Diabetes Mellitus, Type 2
Female
Humans
Hyperkalemia
Incidence
Male
Middle Aged
Naphthyridines
Potassium
Proportional Hazards Models
Renal Insufficiency, Chronic
Risk Factors
authors with profiles
George Bakris
Daniel J. Wilson